Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review

Published:2022-03-22 Issue:6 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

McGaugh Scott¹,Kallis Penelope¹,De Benedetto Anna²,Thomas Renee M.³

Affiliation:

1. Department of Dermatology, College of Medicine University of Florida Gainesville Florida USA

2. Department of Dermatology University of Rochester Medical Center Rochester New York USA

3. Department of Dermatology C. W. Bill Young Veterans Affairs Medical Center Bay Pines Florida USA

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15437

Reference38 articles.

1. Classification of Morphea (Localized Scleroderma)

2. Morphea and Eosinophilic Fasciitis: An Update

3. Systemic sclerosis: Current concepts of skin and systemic manifestations

4. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960‐1993;Peterson LS;J Rheumatol,1997

5. Antinuclear Antibodies in Systemic Sclerosis: an Update

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single‐center experience;International Journal of Rheumatic Diseases;2024-08

2. Successful therapy of refractory cutaneous morphea with tofacitinib;Italian Journal of Dermatology and Venereology;2024-07

3. Assessment of serum and cutaneous JAK3 in juvenile scleroderma;The Egyptian Journal of Pediatric Allergy and Immunology;2024-04-01

4. S2k‐Leitlinie: Diagnostik und Therapie der zirkumskripten Sklerodermie;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-04

5. S2k guideline: Diagnosis and therapy of localized scleroderma;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3